FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121498982> ?p ?o ?g. }

• W2121498982 endingPage "646" @default.
• W2121498982 startingPage "641" @default.
• W2121498982 abstract "The objectives of this national chart audit (January to June 2013) of 6,346 patients with atrial fibrillation (AF; ≥18 years without a significant heart valve disorder) from 647 primary care physicians were to (1) describe the frequency of stroke and bleed risk assessments in patients with nonvalvular AF by primary care physicians, including the accuracy of these assessments relative to established predictive indexes; (2) outline contemporary methods of anticoagulation used; and (3) report the time in the therapeutic range among patients prescribed warfarin. An annual stroke risk assessment was not undertaken in 15% and estimated without a formal risk tool in 33%; agreement with CHADS2 score estimation was seen in 87% of patients. Major bleeding risk assessment was not undertaken in 25% and estimated without a formal risk tool in 47%; agreement with HAS-BLED score estimation was observed in 64% with physician overestimation in 26% of patients. Antithrombotic therapy included warfarin (58%), dabigatran (22%), rivaroxaban (14%), and apixaban (<1%). Among warfarin-treated patients, the median international normalized ratio was 2.4 and time in therapeutic range (TTR) was 73%; however, the TTR was <50% in 845 (25%), 50% to 69% in 674 (20%), and ≥70% in 1,827 (55%) patients. In conclusion, we describe a contemporary real-world elderly population with AF at important risk for stroke. There is apparent overestimation of bleeding risk in many patients. Warfarin was the dominant stroke prevention treatment; however, the suggested TTR target was achieved in only 55% of these patients. The objectives of this national chart audit (January to June 2013) of 6,346 patients with atrial fibrillation (AF; ≥18 years without a significant heart valve disorder) from 647 primary care physicians were to (1) describe the frequency of stroke and bleed risk assessments in patients with nonvalvular AF by primary care physicians, including the accuracy of these assessments relative to established predictive indexes; (2) outline contemporary methods of anticoagulation used; and (3) report the time in the therapeutic range among patients prescribed warfarin. An annual stroke risk assessment was not undertaken in 15% and estimated without a formal risk tool in 33%; agreement with CHADS2 score estimation was seen in 87% of patients. Major bleeding risk assessment was not undertaken in 25% and estimated without a formal risk tool in 47%; agreement with HAS-BLED score estimation was observed in 64% with physician overestimation in 26% of patients. Antithrombotic therapy included warfarin (58%), dabigatran (22%), rivaroxaban (14%), and apixaban (<1%). Among warfarin-treated patients, the median international normalized ratio was 2.4 and time in therapeutic range (TTR) was 73%; however, the TTR was <50% in 845 (25%), 50% to 69% in 674 (20%), and ≥70% in 1,827 (55%) patients. In conclusion, we describe a contemporary real-world elderly population with AF at important risk for stroke. There is apparent overestimation of bleeding risk in many patients. Warfarin was the dominant stroke prevention treatment; however, the suggested TTR target was achieved in only 55% of these patients." @default.
• W2121498982 created "2016-06-24" @default.
• W2121498982 creator A5005825589 @default.
• W2121498982 creator A5011573170 @default.
• W2121498982 creator A5012672874 @default.
• W2121498982 creator A5017666786 @default.
• W2121498982 creator A5020373936 @default.
• W2121498982 creator A5026161853 @default.
• W2121498982 creator A5037522111 @default.
• W2121498982 creator A5047187243 @default.
• W2121498982 creator A5048041063 @default.
• W2121498982 creator A5051732723 @default.
• W2121498982 creator A5052517103 @default.
• W2121498982 creator A5064052704 @default.
• W2121498982 creator A5065441662 @default.
• W2121498982 creator A5068138290 @default.
• W2121498982 creator A5071425488 @default.
• W2121498982 creator A5074414470 @default.
• W2121498982 creator A5076611566 @default.
• W2121498982 creator A5084015464 @default.
• W2121498982 date "2015-03-01" @default.
• W2121498982 modified "2023-10-17" @default.
• W2121498982 title "Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit)" @default.
• W2121498982 cites W1586488555 @default.
• W2121498982 cites W1969744856 @default.
• W2121498982 cites W1985004555 @default.
• W2121498982 cites W1995044128 @default.
• W2121498982 cites W2011936209 @default.
• W2121498982 cites W2062786076 @default.
• W2121498982 cites W2086488338 @default.
• W2121498982 cites W2127985968 @default.
• W2121498982 cites W2128415369 @default.
• W2121498982 cites W2141347595 @default.
• W2121498982 cites W2161342715 @default.
• W2121498982 cites W2162586165 @default.
• W2121498982 cites W2166152583 @default.
• W2121498982 cites W2168129104 @default.
• W2121498982 doi "https://doi.org/10.1016/j.amjcard.2014.12.022" @default.
• W2121498982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25727083" @default.
• W2121498982 hasPublicationYear "2015" @default.
• W2121498982 type Work @default.
• W2121498982 sameAs 2121498982 @default.
• W2121498982 citedByCount "17" @default.
• W2121498982 countsByYear W21214989822015 @default.
• W2121498982 countsByYear W21214989822016 @default.
• W2121498982 countsByYear W21214989822017 @default.
• W2121498982 countsByYear W21214989822019 @default.
• W2121498982 countsByYear W21214989822020 @default.
• W2121498982 countsByYear W21214989822022 @default.
• W2121498982 countsByYear W21214989822023 @default.
• W2121498982 crossrefType "journal-article" @default.
• W2121498982 hasAuthorship W2121498982A5005825589 @default.
• W2121498982 hasAuthorship W2121498982A5011573170 @default.
• W2121498982 hasAuthorship W2121498982A5012672874 @default.
• W2121498982 hasAuthorship W2121498982A5017666786 @default.
• W2121498982 hasAuthorship W2121498982A5020373936 @default.
• W2121498982 hasAuthorship W2121498982A5026161853 @default.
• W2121498982 hasAuthorship W2121498982A5037522111 @default.
• W2121498982 hasAuthorship W2121498982A5047187243 @default.
• W2121498982 hasAuthorship W2121498982A5048041063 @default.
• W2121498982 hasAuthorship W2121498982A5051732723 @default.
• W2121498982 hasAuthorship W2121498982A5052517103 @default.
• W2121498982 hasAuthorship W2121498982A5064052704 @default.
• W2121498982 hasAuthorship W2121498982A5065441662 @default.
• W2121498982 hasAuthorship W2121498982A5068138290 @default.
• W2121498982 hasAuthorship W2121498982A5071425488 @default.
• W2121498982 hasAuthorship W2121498982A5074414470 @default.
• W2121498982 hasAuthorship W2121498982A5076611566 @default.
• W2121498982 hasAuthorship W2121498982A5084015464 @default.
• W2121498982 hasConcept C11783203 @default.
• W2121498982 hasConcept C12174686 @default.
• W2121498982 hasConcept C126322002 @default.
• W2121498982 hasConcept C127413603 @default.
• W2121498982 hasConcept C164705383 @default.
• W2121498982 hasConcept C194828623 @default.
• W2121498982 hasConcept C2776301958 @default.
• W2121498982 hasConcept C2777015399 @default.
• W2121498982 hasConcept C2778661090 @default.
• W2121498982 hasConcept C2778810321 @default.
• W2121498982 hasConcept C2779134260 @default.
• W2121498982 hasConcept C2779161974 @default.
• W2121498982 hasConcept C2780638905 @default.
• W2121498982 hasConcept C2780645631 @default.
• W2121498982 hasConcept C2780971015 @default.
• W2121498982 hasConcept C2908647359 @default.
• W2121498982 hasConcept C38652104 @default.
• W2121498982 hasConcept C41008148 @default.
• W2121498982 hasConcept C71924100 @default.
• W2121498982 hasConcept C78519656 @default.
• W2121498982 hasConcept C99454951 @default.
• W2121498982 hasConceptScore W2121498982C11783203 @default.
• W2121498982 hasConceptScore W2121498982C12174686 @default.
• W2121498982 hasConceptScore W2121498982C126322002 @default.
• W2121498982 hasConceptScore W2121498982C127413603 @default.
• W2121498982 hasConceptScore W2121498982C164705383 @default.
• W2121498982 hasConceptScore W2121498982C194828623 @default.
• W2121498982 hasConceptScore W2121498982C2776301958 @default.
• W2121498982 hasConceptScore W2121498982C2777015399 @default.

• next